Sergiusz Markowicz

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Cancer cells accelerate exhaustion of persistently activated mouse CD4+ T cells.

Cancer cells accelerate exhaustion of persistently activated mouse CD4+ T cells.

Journal: Oncoimmunology

Published: June 19, 2025

New molecular targets in Hodgkin and Reed-Sternberg cells.

New molecular targets in Hodgkin and Reed-Sternberg cells.

Journal: Frontiers in immunology

Published: January 31, 2023

RRM2 gene expression depends on BAF180 subunit of SWISNF chromatin remodeling complex and correlates with abundance of tumor infiltrating lymphocytes in ccRCC.

RRM2 gene expression depends on BAF180 subunit of SWISNF chromatin remodeling complex and correlates with abundance of tumor infiltrating lymphocytes in ccRCC.

Journal: American journal of cancer research

Published: September 04, 2021

PD-L1 Overexpression, SWI/SNF Complex Deregulation, and Profound Transcriptomic Changes Characterize Cancer-Dependent Exhaustion of Persistently Activated CD4+ T Cells.

PD-L1 Overexpression, SWI/SNF Complex Deregulation, and Profound Transcriptomic Changes Characterize Cancer-Dependent Exhaustion of Persistently Activated CD4+ T Cells.

Journal: Cancers

Published: June 29, 2021

Imatinib inhibits the regrowth of human colon cancer cells after treatment with 5-FU and cooperates with vitamin D analogue PRI-2191 in the downregulation of expression of stemness-related genes in 5-FU refractory cells.

Imatinib inhibits the regrowth of human colon cancer cells after treatment with 5-FU and cooperates with vitamin D analogue PRI-2191 in the downregulation of expression of stemness-related genes in 5-FU refractory cells.

Journal: The Journal of steroid biochemistry and molecular biology

Published: June 15, 2018

The Effect of Analogues of 1α,25-Dihydroxyvitamin D₂ on the Regrowth and Gene Expression of Human Colon Cancer Cells Refractory to 5-Fluorouracil.

The Effect of Analogues of 1α,25-Dihydroxyvitamin D₂ on the Regrowth and Gene Expression of Human Colon Cancer Cells Refractory to 5-Fluorouracil.

Journal: International journal of molecular sciences

Published: May 10, 2016

Human regulatory T cells suppress proliferation of B lymphoma cells.

Human regulatory T cells suppress proliferation of B lymphoma cells.

Journal: Leukemia & lymphoma

Published: January 14, 2016

MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy.

MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy.

Journal: PloS one

Published: November 09, 2015

Lenalidomide potentiates CD4+CD25+Treg-related suppression of lymphoma B-cell proliferation.

Lenalidomide potentiates CD4+CD25+Treg-related suppression of lymphoma B-cell proliferation.

Journal: Clinical and experimental medicine

Published: September 24, 2015

Differential interference of vitamin D analogs PRI-1906, PRI-2191, and PRI-2205 with the renewal of human colon cancer cells refractory to treatment with 5-fluorouracil.

Differential interference of vitamin D analogs PRI-1906, PRI-2191, and PRI-2205 with the renewal of human colon cancer cells refractory to treatment with 5-fluorouracil.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: September 17, 2015

FOXO1 is a TXN- and p300-dependent sensor and effector of oxidative stress in diffuse large B-cell lymphomas characterized by increased oxidative metabolism.

FOXO1 is a TXN- and p300-dependent sensor and effector of oxidative stress in diffuse large B-cell lymphomas characterized by increased oxidative metabolism.

Journal: Oncogene

Published: September 09, 2015

Imatinib Inhibits the Renewal and Tumorigenicity of CT-26 Colon Cancer Cells after Cytoreductive Treatment with Doxorubicin.

Imatinib Inhibits the Renewal and Tumorigenicity of CT-26 Colon Cancer Cells after Cytoreductive Treatment with Doxorubicin.

Journal: Archivum immunologiae et therapiae experimentalis

Published: June 26, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026